BARDA
Capital Type
Government / Public Funder
Investment Size
Varies by award
Geographic Scope
US, Global
Return Model
Non-Dilutive
Stage Focus
Advanced preclinical, Clinical, Regulatory
Modality Focus
Antibiotics, Diagnostics, Medical countermeasures
Overview
US government medical countermeasure funder with a dedicated antibacterial countermeasures program supporting therapeutics and diagnostics against resistant pathogens.
Portfolio and Signals
Important late-stage signal for anti-infectives because BARDA commonly supports expensive development, manufacturing, and regulatory work beyond what seed VCs can fund.
Access and Engagement
Access is through government solicitations, BAAs, and formal proposal processes.
Notable AMR Examples / Programs
Advanced development and manufacturing support for antibacterial countermeasures
Stay Updated
Stay connected so that you don't miss the latest AMR insights and updates.
